Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-8-3
|
pubmed:abstractText |
BACKGROUND--Earlier studies of aerosol deposition in the lungs have relied on indirect labelling of Teflon spheres of a similar size distribution to the drug in question and have assumed similar aerodynamic properties. Using a modification of a new technique for directly labelling salbutamol, the deposition of salbutamol within the lungs of normal subjects and patients with asthma has been studied with the use of a metered dose inhaler (MDI) alone, an MDI with a spacer device, and a dry powder inhaler (DPI). METHOD--Salbutamol was directly labelled with technetium-99m and placed in an MDI or DPI. Ten normal subjects and 19 patients with asthma inhaled 200 micrograms of salbutamol by means of the MDI alone, the MDI with a spacer device attached, and by DPI on separate days. Deposition was assessed by a dual headed gamma camera after inhalation of the drug. RESULTS--The total mean (SD) percentage deposition of the drug in the normal subjects was 21.6% (8.9%) with the MDI alone, 20.9% (7.8%) with the MDI with spacer, and 12.4% (3.5%) with the DPI. For the patients, the mean percentage deposition was 18.2% (7.8%) with the MDI alone, 19.0% (8.9%) with the MDI and spacer, and 11.4% (5.0%) with the DPI. Bronchodilatation achieved by the patients was similar with all three techniques. Mean peripheral lung deposition was significantly greater with a spacer device than when the MDI was used alone in both normal subjects (49.4% (6.1%) v 44.1% (9.9%)) and patients (38.6% (11.1%) v 30.4% (9.4%)). CONCLUSIONS--The deposition of directly labelled salbutamol from an MDI is greater than previously estimated by indirect labelling techniques. The deposition of labelled salbutamol from a DPI, however, is little different from that measured by indirect techniques.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-1750017,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-2038731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-2392793,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-2588205,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-2899338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-3065810,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-6458460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-7067753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8322237-7307637
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0040-6376
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
506-11
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8322237-Adult,
pubmed-meshheading:8322237-Aged,
pubmed-meshheading:8322237-Albuterol,
pubmed-meshheading:8322237-Asthma,
pubmed-meshheading:8322237-Drug Delivery Systems,
pubmed-meshheading:8322237-Female,
pubmed-meshheading:8322237-Humans,
pubmed-meshheading:8322237-Lung,
pubmed-meshheading:8322237-Male,
pubmed-meshheading:8322237-Middle Aged,
pubmed-meshheading:8322237-Nebulizers and Vaporizers,
pubmed-meshheading:8322237-Technetium
|
pubmed:year |
1993
|
pubmed:articleTitle |
Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.
|
pubmed:affiliation |
Department of Thoracic Medicine, University College Hospital, London.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|